Clinical Trial Site Feasibility Assessments
Determining Feasibility - A Simple Question but a Complicated Process.
One of the overarching aims of PACT is to implement resources to maximise local PF clinical trial activity and capacity.
Determining clinical trial feasibility is an essential site assessment process and involves asking the question – if a clinical trial is run at a particular site, will it be successful? Answering that question, however, is a complicated and time-consuming process.
Sponsors need to investigate and identify trial sites that have the participants, staff, expertise and technology to successfully conduct their study.
Trial sites need to understand what sponsors are looking for, as well as evaluate their own resources to decide whether a trial is a good match for their site.
The clinical trial feasibility process is time-consuming, expensive BUT vital.
What is the Australasian PF Trial Site Feasibility Index?
The PACT Australasian PF Trial Site Feasibility Index is a platform that streamlines and optimises the feasibility data collection process. It saves sponsors and trial sites time by reducing the completion and collection of endless paperwork and eliminating the need to contact sites directly at the initial site assessment stage.
The aim of the Feasibility Index is to:
- Guide trial site contact so that it is more targeted, with sponsors and CROs only offering participation to sites with capabilities relevant to their planned trial.
- Enable a broader range of trial sites to be visible to sponsors and CROs, bringing trial participation to sites and regions beyond the traditional expert centres, thus helping to improve equity of access.